ID: ALA4871075

Max Phase: Preclinical

Molecular Formula: C13H13BrFN3O3

Molecular Weight: 358.17

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Cc1ncc([N+](=O)[O-])n1CCOCc1ccc(F)cc1Br

Standard InChI:  InChI=1S/C13H13BrFN3O3/c1-9-16-7-13(18(19)20)17(9)4-5-21-8-10-2-3-11(15)6-12(10)14/h2-3,6-7H,4-5,8H2,1H3

Standard InChI Key:  OLNRTFSDGRXLRP-UHFFFAOYSA-N

Associated Targets(non-human)

Pancreatic alpha-amylase 211 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 358.17Molecular Weight (Monoisotopic): 357.0124AlogP: 3.22#Rotatable Bonds: 6
Polar Surface Area: 70.19Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 3.03CX LogP: 2.82CX LogD: 2.82
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.45Np Likeness Score: -2.13

References

1. Patel OPS, Jesumoroti OJ, Legoabe LJ, Beteck RM..  (2021)  Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.,  210  [PMID:33234343] [10.1016/j.ejmech.2020.112994]

Source